chrisvoncsefalvay/vaers-outcomes huggingface dataset:
83 year old male with hx of HLD, on metoprolol, denied HTN by daughter, takes it for essential tremors, DM2, hypothyroidism, essential tremors, dementia, and urinary frequency presents for evaluation of weakness and fatigue for the past 3 days, family states he was not himself, denies chest pain or sob, found to be hypoxic on room air 88% and improved to 96-98% with 6 liters of oxygen. He has dementia but normally does not speak much, says yes to almost everything and when he does not know people he does not speak per daughter. He had a fever of 101.5 upon arrival and it is down to 100.5 post Tylenol. He is currently COVID 19 positive and is dually vaccinated with Moderna, has not gotten boosted yet. He denies any nausea or vomiting or any other complaints.
Started having pleuritic chest pain on date provided, went to ED, troponin was 4, diagnosed with probable myocarditis. Also had false positive covid POC and 2 Negative PCR tests with 24hrs of admission. CRP  and ESR both High. Require CTA chest to rule out PE which was negative.  Currently pregnant, first child, EDD 3/1/22
Initial report received from healthcare professional on 22 April 2014. The '64-year-old' female patient's initials was not provided, whose medical history and concomitant medication were not reported, had received dose of TETANUS (TETANUS TOXOID) on an unspecified date. (Lot number and expiration date, dose number was not reported) and on an unspecified date patient had experienced numbness, and dizziness. The laboratory details and corrective treatment were not reported. The outcome of the event was unknown at the time of report. List of documents held by sender: none.
Extreme fatigue; Head aches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue) and HEADACHE (Head aches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Extreme fatigue) and HEADACHE (Head aches). At the time of the report, FATIGUE (Extreme fatigue) and HEADACHE (Head aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Received Moderna vaccines on 2/13, 3/13, 9/29/21; COVID positive on 4/24/22; admitted to hospital on 4/24/22 d/t respiratory failure w/ hypoxia; COVID infection. Treated w/ remdesivir and dexamethasone; underlying lung cancer and malignant pleural effusion.
Swelling and discomfort to injection site and armpit area. Swelling and redness over left axillary lymph node. Treated with 10 day CEFZIL course.
Rash macular; rash erythematous Information has been received from a physician assistant concerning a 57 year old female who on 08-SEP-2005 was vaccinated IM with a one milliliter dose of hepatitis A virus vaccine inactivated (lot #649456/0501R). On 09-SEP-2005 the patient experienced an erythematous macular rash limited mostly to her legs and arms. The rash has been treated with two IV methylprednisolone sodium succinate (Solu-Medrol) treatments, a methylprednisolone (MEDROL) dose pack and over the counter diphenhydramine (Benadryl). It was reported that improvement post treatment has been minimal. No other information was available. The patient is no recovered. There was no product quality complain reported. The patient sought unspecified medical attention. Additional information has been requested.
10/15/2022 I had a headache almost immediately with aches and pains and my fingertips had a burning sensation and heart palpitations and tachycardia within a few hours of getting the vaccine. I had a sharp pain running up and down the left side of my neck. I had some fatigue and brain fog. That evening I developed a fever peaking at 102. I took TYLENOL and the next morning the fever was broken. The rest of the symptoms lasted about 10 days. Saw Dr. about heart issues 11/14. She referred me to a cardiologist.
Admitted to the hospital for low sodium; Malaise; Night sweats; fever; Swollen glands; Numb fingers and toes; Cramp to right lower leg; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD SODIUM DECREASED (Admitted to the hospital for low sodium), MALAISE (Malaise), NIGHT SWEATS (Night sweats), PYREXIA (fever) and LYMPHADENOPATHY (Swollen glands) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 018B21A and 003C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BLOOD SODIUM DECREASED (Admitted to the hospital for low sodium) (seriousness criterion hospitalization prolonged), MALAISE (Malaise) (seriousness criterion hospitalization prolonged), NIGHT SWEATS (Night sweats) (seriousness criterion hospitalization prolonged), PYREXIA (fever) (seriousness criterion hospitalization prolonged), LYMPHADENOPATHY (Swollen glands) (seriousness criterion hospitalization prolonged), HYPOAESTHESIA (Numb fingers and toes) and MUSCLE SPASMS (Cramp to right lower leg). The patient was hospitalized on 15-May-2021 due to BLOOD SODIUM DECREASED, LYMPHADENOPATHY, MALAISE, NIGHT SWEATS and PYREXIA. The patient was treated with FUROSEMIDE (LASIX [FUROSEMIDE]) at a dose of 1 dosage form and SODIUM CHLORIDE at a dose of 1 dosage form. At the time of the report, BLOOD SODIUM DECREASED (Admitted to the hospital for low sodium), MALAISE (Malaise), NIGHT SWEATS (Night sweats), PYREXIA (fever), LYMPHADENOPATHY (Swollen glands), HYPOAESTHESIA (Numb fingers and toes) and MUSCLE SPASMS (Cramp to right lower leg) outcome was unknown.            Concomitant medication was not reported.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
In March of 2021, I don't remember the exact date, but that's when I noticed when my blood pressure was high. I contacted my doctor in March, he made an appointment for me to come in, in March 2021. During my doctors appointment they checked me all over and then check my blood pressure and prescribe me a blood pressure pill, losartan.  After my doctors appointment, I would check my blood pressure twice a day and I noticed that the losartan was not working so I called my doctor; to setup an appointment for in May 2021. For my May 2021 doctors appointment, Doctor checked my blood pressure again and it was till high so he prescribe me a different pill Beta-Blocker blood pressure pill in June  2021. None of the pills worked and so Doctor put me on Norvasc blood pressure pill. None of these pills have helped my blood pressure.
Patient began having problems with hives about 2 1/2 days following vaccination. They began traveling up the body towards the face. Benadryl wasn't really keeping them under control. On day 4 following vaccination they made a visit to their healthcare provider. At that time, the provider had patient start taking Zyrtec daily. About 1 1/2 weeks after vaccination he was still having trouble with hives on and off with not much relief. After a call to the healthcare provider, they added Claritin daily to his medicine regimen along with continuing Benadryl as needed. At almost two weeks following vaccination, patient encounters the hives about once at day, around two in the morning. They haven't gone away.  Mother reports no other issues at this time. Patient has not had issues with vaccination in the past.
Information has been received from a nurse practitioner concerning a 43 year old patient who on 27-JUL-2010 was inadvertently vaccinated with ZOSTAVAX (Merck) instead of VARIVAX (Merck). The patient sought unspecified medical attention. All telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.
Persistent muscle weakness,joint pain,headache and left foot numbness following first anthrax vaccine.  Patient received Anthrax #1 on 12 Jan. 2003.  On day one, developed flu-like symptoms of headache, myalgia/arthralgia, denies fever.  On Day 3, he attempted to engage in exercise and experienced  generalized muscle weakness,joint pain and headache x 4 days.  Pain rated 7/10 of right shoulder, bilateral knees and hips.  Also c/o mid-back pain and numbness of the left foot occurring around the same time.  He has completed 4 series of the anthrax vaccine. States muscle weakness and joint pain has been ongoing x 10 months and worsened after each anthrax vaccines. The headaches have been occurring intermittently and lasting 3-4 days with occasional dizziness and difficulty concentrating and "focusing".  Numbness is localized to the lateral left foot.
Symptoms are headache, backache, shortness of breath, leg swelling. Symptoms have lasted 6 days.
Extreme tiredness; sweating; confusion; This is a spontaneous report received from a non-contactable consumer (patient herself). A 38-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 26Mar2021 10:00 (lot number: unknown) as single dose for covid-19 immunisation. Prior to vaccination, the patient was diagnosed with COVID-19. Pregnant at the time of vaccination was no. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's concomitant medications were not reported. The patient experienced extreme tiredness extreme tiredness, sweating and confusion on 26Mar2021 with outcome of not recovered. No treatment was received for events.  Since the vaccination, the patient had not been tested for COVID-19.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Red arm,  2 inches below injection site. Hot to the touch. Started 1/30/21.  Got a bit better 2/3/21. Symptoms returned 2/6/21.  The redness has enlarged. Still hot to the touch.  I went to my doctor 2/8/21.  She believes it is Cellulitis.  She has prescribed Cephalexin 500 mg.
chills; fever; This is a spontaneous report from a contactable nurse reporting for herself. A 32-years-old female patient started to receive the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), on 07JAN2021 11:00 (at the age of 32-years-old) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported.  The patient previously had BNT162B2 dose 1 for COVID-19 immunization. The patient had been experiencing chills and fever after she received the second dose of the Covid-19 vaccine on 07Jan2021 11:00AM. The symptoms started on 08Jan2021 around 3:00AM, she's still experiencing these symptoms and she took acetaminophen (TYLENOL) to lessen symptoms.  Outcome of the events was not recovered.  Information on batch/lot number requested.
Sore arm immediately.  Headache, body aches and chills started within 3 hours.  This lasted for 2 days.  I had an off and on headache for a couple more days.
STING; This spontaneous report received from a patient concerned a 67 year old male. The patient's weight was 200 pounds, and height was 74 inches. The patient's concurrent conditions included type 2 diabetic, allergy to cats, no alcohol consumption, and no smoking, and other pre-existing medical conditions included patient had no drug abuse or illicit allergy.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, once a total administered on 06-MAR-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported. On 06-MAR-2021, the subject experienced sting. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sting on 06-MAR-2021. This report was non-serious.
Information has been received from a consumer concerning her 39 month old daughter with a history  of "fever with all vaccines" who when she was 'less then 1 year old was vaccinated with a dose of Hib conj vaccine (OMPC). On approximately 10-DEC-2007 was vaccinated with a dose of Hib conj vaccine (OMPC). There was no concomitant medication. On 11-DEC-2007 the patient experienced "very high fever, constant throwing up, and leg also became swollen and red." The patient was described as "violently ill." Unspecified medical attention was sought. At the time of the report, the patient was recovering. It was reported that her "stomach still hurts." Additional information has been requested. This is in follow-up to report (s) previously submitted on 2/18/20078. Previous vaccines included: ACTHIB (lot # ub878aa) on 03-Nov-2004, FLUARIX (lot # UT2459HA) (date not reported), HAVARIX (lot #AHAVB2066A) (date not reported), PEDIARIX (lot # AC21B30AA) on 03-Oct-2004 and PREVNAR (lot # 80865) on 03-Nov-2004. Additional information is not expected.
No adverse event; Lot that had been expired was administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Lot that had been expired was administered to patient) and NO ADVERSE EVENT (No adverse event) in a 73-year-old female patient who received mRNA-1273 (Spikevax) (batch no. O70H21A) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Lot that had been expired was administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Lot that had been expired was administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Lot that had been expired was administered to patient).      Person number was reported   Patient age was reported as 73 years 06 months.    No concomitant medications were reported.     Completion date was reported as 28-Apr-2022.     Reportedly, the number of patients at facility that received this Moderna vaccine between 08-Apr-2022 and 15-Dec-2022 from the vial with lot number O70H21A.   No treatment medications were reported.
2 bouts of vertigo; nose a little sore and irritated; Rash on nose; A spontaneous report was received from a physician concerning a 55-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced rash on nose, nose a little sore and irritated, and 2 bouts of vertigo.  The patient's medical history was not provided. Concomitant medications reported included estradiol and progesterone.  On 23 Dec 2020, approximately 2 hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (BATCH #025J20A) intramuscularly for prophylaxis of COVID-19 infection.  On 23 Dec 2020, within 2 hours of vaccine administration, the patient reported developing a small rash that came up as a blister, on her nose. She used clindamycin ointment on the area and the rash resolved the same day. The patient reported that the area is now sore and irritated. On 26 Dec 2020, the patient reported experiencing 2 bouts of vertigo at 10:30 pm, which she says is unusual for her.   Treatment for the event included topical clindamycin ointment.   Action taken with mRNA-1273 in response to the events was not reported.  The event, rash on nose, was considered resolved on 23 Dec 2020. The event, 2 bouts of vertigo, was considered resolved on 26 Dec 2020. The outcome of the event, nose a little sore and irritated, was unknown.; Reporter's Comments: This case concerns a 55 year old female with unknown medical history who experienced the nonserious unlisted events of vertigo, rash, and skin irritation. The event of vertigo occurred 3 days after the first dose of mRNA-1273, rash the same day as mRNA-1273, and skin irritation occurred 2 days after mRNA-1273.  Based on the current available information and close temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Numbness and tingling on chin asometimes up to nose and bouts of dizziness.
Upper left arm muscle is still sore and tender, even after 6 months, also weakness in left upper arm.
He "felt a little frog in his arm"at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (He "felt a little frog in his arm"at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE REACTION (He "felt a little frog in his arm"at the injection site). At the time of the report, VACCINATION SITE REACTION (He "felt a little frog in his arm"at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.
A quarter sized red patch formed at location of vaccination shot 4 days after administered. The area became hot to touch, raised, and itchy. Since first start of this event, the red circle shaped rash gradually grew, becoming increasingly itchy and inflamed. Patient began applying cold compress and hydrocortisone topical cream 1-2x daily. Patient contacted health care professional on 12/2/21 to report event. Health care provider prescribed Triamcinolone 0.1% Cream 30gm to be applied 4-5x daily. Patient is now using the prescription provided and continuing to apply cold compress. As of today, 12/3/21, patient is still experiencing symptoms, more specifically, rash is growing, itching, and inflamed and is continuing treatment.
Pain in upper arm, pain in hand and fingers, some chest pain, severe pain in left eye and above eye....  this all seems to have fixed itself for now do not have pain.
Initial report received from a healthcare professional on 21 October 2013. A 72 year old female patient whose concomitant medications were not reported, received a dose of FLUZONE HD (lot number: U4784AA, expiry date: unknown) on left deltoid via intramuscular route on 18 October 2013. Patient experienced soreness, redness, swelling at injection site with red ring that covered deltoid, biceps to the underarm area on 18 October 2013. Patient took ZYRTEC 10 mg for 3 days. Patient had allergy to CECLOR. List of documents held by sender: none.
gave the patient a smaller than regular amount was suppsoed to be 0.3ml doses under 0.15ml when administered called pzifer to get resolution on subject they said to readminster the dose in the opposite arm called patient left message waiting for them call back but we will administer following thier instructions---=shot happed at 9:30am on 8/9
Information has been received from an office manager referring to multiple patients of unknown age and gender. The patients' medical history, concurrent condition and concomitant therapy were not reported. On unknown dates, the patients were vaccinated with improperly stored ROTATEQ (lot # M019706, expiration date 24-OCT-2017, dose not reported) orally for prophylaxis. The doses of vaccine were improperly stored at 34.4 degree Fahrenheit (F) for 63 hours. There was no previous temperature excursion. No data logger was involved. No adverse effects were reported. Additional information has been requested.
Woke up around day 6-8 with a rash on my hands, by day 10 rash spread from my fingers/palms/hands up arms...onto belly...legs...feet/toes...itchy, but sore. Went to ER on 04/26 at approx 12pm, rash suggested to be eczema  allergy with cellulitis.  Given topical steroid cream, keflex. Rash got worse and went to doctor for rash. I suggested then that it could be the covid shot because this was the only new thing. PA I saw said possibly but suggested allergy. Gave me oral steroids, pepcid, and Claritin.  Rash still grew, achy joints..severe itch. At this point I developed open blisters on my toes. Pain & itchy. Went to ER again and was told it could be from my covid shot but they couldn?t confirm. Took blood, tested for lymes..full body rash that resembled measles..took me off of keflex and Claritin, gave me doxycycline and benedryl. Lymes negative. Again covid shot mentioned. No confirmation..just a lot of ?well it?s possible...? really sleepy, elevated BP. Rash fading, but still very visible as of 5/06. Not as itchy, but still full body
convuls, sweating, shakes, stomach cramps, vomiting, high pitch cries, rash over entire body, puffy eyes, pus inside eyes;
Frontal headache starting day 7 post-vaccine and continuing until approximately day 14 post-vaccine. No neurological changes experienced. Tylenol and/or Ibuprofen ineffective.